ChronoScale Corporation Finalizes Business Combination, Secures $15.75M PIPE, and Reconstitutes Board

summarizeSummary

Ekso Bionics Holdings, Inc. completed its business combination, changing its name to ChronoScale Corporation and shifting its focus to cloud computing, with existing shareholders experiencing extreme dilution and a loss of control.

check_boxKey Events

• Business Combination Completed and Name Change

  Ekso Bionics Holdings, Inc. consummated its previously announced business combination, changing its name to ChronoScale Corporation and acquiring Applied Digital Cloud Corporation, a cloud computing business, as a wholly-owned subsidiary. The company's ticker symbol is now CHRN.

• Significant PIPE Investment and Extreme Dilution

  Applied Digital Corporation purchased 1,311,407 shares for approximately $15.75 million at $12.01 per share. Following the combination, Applied Digital Corporation and its subsidiary now hold approximately 97% of the outstanding common stock, leaving legacy shareholders with about 3%. The authorized common shares were increased to 290,000,000, representing over 100% potential dilution if all authorized shares were issued relative to current outstanding shares.

• Major Governance Overhaul and Loss of Control

  The company is now a 'controlled company' under Nasdaq rules. Applied Digital Corporation has the right to designate four of seven directors, including the Chairman, and holds veto power over significant corporate actions such as mergers, asset sales, charter amendments, and large capital expenditures, as long as it maintains at least 30% ownership. Stockholder action by written consent is only permitted if Applied Digital owns over 50% of voting power, and common stockholders cannot call special meetings.

• New Leadership and Equity Incentive Plan

  Ying Cenly Chen was appointed as the new Chief Executive Officer, with a base salary of $650,000 and a target annual bonus of 100% of her base salary, along with a grant of 2,800,000 restricted stock units. Jerome Wong was appointed Chief Financial Officer. The company adopted a new 2026 Omnibus Equity Incentive Plan, authorizing 22,500,000 shares for future awards.

auto_awesomeAnalysis

This 8-K/A filing details the consummation of a business combination that fundamentally transforms Ekso Bionics Holdings, Inc. into ChronoScale Corporation, a cloud computing focused entity. The transaction results in extreme dilution for legacy shareholders, who now collectively own approximately 3% of the combined company, while Applied Digital Corporation and its subsidiary gain 97% ownership. The $15.75 million PIPE investment, while providing capital, is part of this highly dilutive restructuring. The new controlling shareholder gains significant governance rights, including the ability to designate a majority of the board and veto power over major corporate actions. This represents a complete shift in the company's business, ownership, and control, making it a thesis-altering event for existing investors.